🔗 Visit the ClinicalTrials.gov page for NCT01653561
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer. | BMC Cancer | 2014 | 0.99 |
| 2 | Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapy. | Breast Cancer Res Treat | 2013 | 0.92 |